Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
about
Site-specific immunosuppression in vascularized composite allotransplantation: prospects and potentialPerioral dermatitis: a review of the condition with special attention to treatment optionsUpdate on the use of topical calcineurin inhibitors in cutaneous lupus erythematosus.FK506-binding protein 12 ligands: a patent review.Immunomodulation and safety of topical calcineurin inhibitors for the treatment of atopic dermatitis.Discovery of topical calcineurin inhibitors and pharmacological profile of pimecrolimus.Review of pimecrolimus cream 1% in children for the treatment of mild to moderate atopic dermatitis.Topical calcineurin inhibitors and lymphoma risk: evidence update with implications for daily practice.Pimecrolimus versus topical corticosteroids in dermatology.What's new in atopic eczema?Innate immunity in atopic dermatitis.Role of dendritic cells in atopic dermatitis: an update.Cutaneous dendritic cells in allergic inflammation.What is new in atopic dermatitis/eczema?Tacrolimus Reverses UVB Irradiation-Induced Epidermal Langerhans Cell Reduction by Inhibiting TNF-α Secretion in Keratinocytes via Regulation of NF-κB/p65.Atopic dermatitis: a review of topical nonsteroid therapy.Inhibition of T-cell activation in vitro in human peripheral blood mononuclear cells by pimecrolimus and glucocorticosteroids and combinations thereof.Diagnosis and treatment of atopic dermatitis in children and adults: European Academy of Allergology and Clinical Immunology/American Academy of Allergy, Asthma and Immunology/PRACTALL Consensus ReportPolymorphisms of the Bcl-2 family member bfl-1 in children with atopic dermatitis
P2860
Q27027795-FD7516E1-A420-45C5-82C8-E8ABB4ED133DQ28235831-259116F9-567E-4072-A84D-B02D43EA8F8FQ34605279-5E3145B6-7AD6-43F4-BBF2-7E4B7AA8134EQ34955459-C23D1398-6FFF-4B5D-9D61-D5CFFC73ED49Q36222741-C5649F91-D8AE-4E47-AE68-2C824398FDAAQ36574341-83815E10-6933-48E8-9DA0-83A76463F298Q36681795-4AC35994-D9F7-4AD1-B8E5-C318BBD6867FQ36892767-61DE1AF0-8289-4FF8-89FA-C526174424ABQ36895865-E213CEDC-1657-4A4F-BE1D-9AF7EBD3FBD8Q37740142-45312446-0B8F-4173-B9D7-34A7205773E4Q37823415-FCF0E5D8-D01E-4014-8587-957CE49F6E2AQ37823416-7ED80777-B419-408E-A009-442A10DEFDB9Q38026993-EFAAFDA9-017E-4054-9845-B4728B7E5A48Q38257104-B8318CEE-E81D-4FB3-B8BE-C1DFDB02761DQ51742573-F7DFBD27-852A-40DA-B063-296B872D1CAFQ52597622-2C7FE725-FCC2-4B95-8D32-7220F6C13238Q53542049-2B96474F-BFF2-450D-B25F-AEC6CD733032Q57072093-C8EF7B09-DD96-4CD4-81E2-AA014A9D7ED7Q57173893-106853EE-299C-411C-9591-572ED2235BF0
P2860
Pimecrolimus leads to an apoptosis-induced depletion of T cells but not Langerhans cells in patients with atopic dermatitis.
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh-hant
name
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@en
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@nl
type
label
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@en
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@nl
prefLabel
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@en
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@nl
P2093
P1476
Pimecrolimus leads to an apopt ...... tients with atopic dermatitis.
@en
P2093
Adelheid Elbe-Bürger
Anton Stuetz
Rupert Ecker
Tamara Kopp
Wolfram Hoetzenecker
P304
P356
10.1016/J.JACI.2005.02.011
P407
P50
P577
2005-06-01T00:00:00Z